Patients admitted to the ICU with a haemoglobin ( Hb ) level < 100 g/L and predicted to require critical care beyond the next calendar day will be randomly assigned in a 1 : 1 ratio to receive IV ferric carboxymaltose ( 500 mg ) or placebo .